Limited Dose Rate Brachytherapy Monotherapy: Inadequate for NCCN UIR Prostate Cancer Patients
2 years ago
91
The following is a summary of “LDR-Brachytherapy monotherapy appears unsuited for NCCN unfavorable intermediate-risk prostate cancer patients,” published...